What is Tuberculosis Testing Market?
Tuberculosis is an infection caused by the bacteria Mycobacterium tuberculosis most often to the lungs. It can also be affecting the other parts of the body. Tuberculosis testing can be done by two methods including TB skin test (TST) and TB blood tests. These tests only tell that a person has been infected with TB bacteria. Other tests are needed to see if the person has latent TB infection or TB disease. According to the World Health Organization (WHO), In 2017, an estimated 4.4 million people fell ill with TB and an estimated 638,000 died because of the disease which is more than half of global TB deaths.
The market study is being classified by Type (TB skin test (TST), TB blood tests and Others), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up.
Abbott Laboratories (United States), Akonni Biosystems, Inc. (United States), Alere, Inc. (United States), Becton, Dickinson, and Company (United States), Cepheid (United States), Epistem Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (United States), bioMérieux SA (France) and Siemens Healthineers Inc. (Germany) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Tuberculosis Testing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Tuberculosis Testing market by Type, Application and Region.
On the basis of geography, the market of Tuberculosis Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Tuberculosis Infection among People
- Increased Number of Diagnostic Centres and Hospitals
- Government Initiatives about Tuberculosis Prevention
- Demand for Advanced Tuberculosis Testing
- Lack of Healthcare Facility in Under Developed Countries
- Growing Healthcare Industry Worldwide
- Rising Awareness among People About Tuberculosis
- The need for Early Detection of the Tuberculosis Disease
Market Leaders and some development strategies
Key Target AudienceTuberculosis Testing Providers, Research Companies, Emerging Companies and End-users